Effects of Esketamine on the Incidence of Postoperative Delirium and Postoperative Sleep Disturbance in Elderly Patients After Major Non-cardiac Surgery
- Conditions
- Postoperative Delirium (POD)Postoperative Sleep Disturbance
- Interventions
- Drug: 0.9 % saline
- First Posted Date
- 2025-03-28
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 644
- Registration Number
- NCT06900205
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Application of Artificial Intelligence Algorithm Based on CT Imaging for Muscle Parameter Measurement
- Conditions
- Deep LearningSarcopeniaComputed TomographyBody Composition
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1080
- Registration Number
- NCT06845462
- Locations
- 🇨🇳
Shanghai Jiaotong University School of Medicine, Renji Hospital Ethics Committee, Shanghai, Shanghai, China
Lecanemab for Early Onset Familial Alzheimer's Disease
- Conditions
- Alzheimer Disease
- First Posted Date
- 2025-03-19
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 114
- Registration Number
- NCT06883019
- Locations
- 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, China
🇨🇳The Second Affiliated Hospital of Guangzhou Medical University, Guangdong, China
🇨🇳The Affiliated Hospital of Guizhou Medical University, Guizhou, China
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
- Conditions
- Quality of Life (QOL)Patient-Reported Outcome Measures (PROMs)Pneumonia ChildhoodNeuroblastoma (NB)Wilms TumourImmune Thrombocytopenic Purpura ( ITP )
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 360
- Registration Number
- NCT06873672
- Locations
- 🇨🇳
Guizhou Medical University, Guiyang, Guizhou, China
A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC
- Conditions
- Advanced Clear Cell Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 28
- Registration Number
- NCT06870279
Trop2-targeted immunoPET Imaging of Solid Tumors
- Conditions
- Solid TumorSolid CarcinomaBladder CancerCholangiocarcinomaOvarian CancerCervical CancerEndometrial CancerUroepithelial CarcinomaNasopharyngeal CancerLiver Cancer
- Interventions
- Drug: [68Ga]Ga-NOTA-T4Drug: [68Ga]Ga-NOTA-RT4Drug: [18F]F-RESCA-T4Drug: [18F]F-RESCA-RT4
- First Posted Date
- 2025-02-28
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06851663
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
CD70-targeted immunoPET Imaging of Malignant Cancers
- Conditions
- Renal CancerRenal Clear Cell CarcinomaLymphomaLymphoma, Large B-Cell, DiffuseFollicular LymphomaMantle Cell LymphomaNasopharyngeal Carcinoma
- Interventions
- Drug: [18F]F-RESCA-RCCB6Drug: [18F]F-RESCA-R8B4Drug: [18F]F-RESCA-RD06Drug: [68Ga]Ga-NOTA-R8B4Drug: [68Ga]Ga-NOTA-RD06Drug: [89Zr]Zr-DFO-RB6Drug: [89Zr]Zr-DFO-R8B4Drug: [89Zr]Zr-DFO-RD06
- First Posted Date
- 2025-02-28
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06852638
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Diagnostic Efficacy Study of AI System in Screening Infants with Developmental Dysplasia of the Hip
- Conditions
- Hip Dysplasia, Developmental
- First Posted Date
- 2025-01-31
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1976
- Registration Number
- NCT06803004
- Locations
- 🇨🇳
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Early Identification and Treatment of Rare Cardiomyopathy Cohorts
- Conditions
- Hypertrophic Cardiomyopathy (HCM)Dilated Cardiomyopathy (DCM)Metabolic CardiomyopathyRestrictive Cardiomyopathy
- Interventions
- Drug: diuretics, ACEIs/ARBs, beta blockers, positive inotropic drugs, MRAs, SGLT2i, retinoidsBehavioral: Close follow-upBehavioral: early rehabilitation guidance
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06794710
- Locations
- 🇨🇳
Renji Hospital, Shanghai, Shanghai, China
Swartz Sheath With Angioplasty Guidewire-Assisted Technique for Patent Foramen Ovale Closure (STAGE-PFO)
- Conditions
- Patent Oval Foramen
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06793969
- Locations
- 🇨🇳
Renji Hospital, Shanghai, China